According to FutureWise analysis the market for Fecal Calprotectin Test in 2023 was US$ 68 Million, and is expected to reach US$ 160 Million by 2031 at a CAGR of 13.1%.
Fecal calprotectin test is a diagnostic test used to measure the level of calprotectin in an individual's stool. Calprotectin is a protein found in white blood cells and is commonly used as a biomarker for inflammation in the intestines, and elevated levels of calprotectin in stool can indicate the presence of inflammation in the gastrointestinal tract. The fecal calprotectin test is used to diagnose and monitor inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis. It is also used to differentiate IBD from other diseases that causes similar symptoms, such as irritable bowel syndrome (IBS).
The test is non-invasive and can be performed easily in a doctor's office or at home with a test kit. The patient collects a small sample of their stool and sends it to a laboratory for analysis. The results of the test are usually available within a few days. The test kit is designed to provide a rapid and accurate result, usually within 15-30 minutes, without requiring laboratory analysis. The test is typically performed using a small stool sample that is collected at home or in a healthcare setting and then processed using the test kit. It is crucial to note that the fecal calprotectin test is not a definitive diagnostic tool for IBD or other digestive disorders, and should be used in combination with other diagnostic tests and clinical evaluation by a healthcare professional.
FutureWise Market Research has published a report that provides an insightful analysis of Fecal Calprotectin Test Market trends that are affecting the overall market growth.
Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Fecal-Calprotectin-Test/11728
Fecal Calprotectin Test Market Segmentation:
By Indication
- Inflammatory Bowel Disease
- Colorectal Cancer
- Celiac Disease
- Others
By Distribution Channel
- Hospitals
- Diagnostic Laboratories
- Academic & Research Institutes
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Fecal Calprotectin Test Market:
- Medixbiochemica
- LifeSpan BioSciences, Inc.
- RayBiotech, Inc.
- Eagle Bioscience, Inc.
- Abbexa Ltd
- Calpro AS
- Epitope Diagnostics, Inc.
- America Diagnosis, Inc.
- Alpha Laboratories
Ask For Discount: https://www.futurewiseresearch.com/contact.aspx?rpt=11728%20&type=discount
**Objectives of this Study: **
- To provide a comprehensive analysis of the Fecal Calprotectin Test Market By Indication, By Distribution Channel and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
FutureWise Research
Contact Person: Vinay Thaploo.
Email: sales@futurewiseresearch.com
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com
